Clever Leaves Holdings Inc
General ticker "CLVR" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $279.8K
Clever Leaves Holdings Inc does not follow the US Stock Market performance with the rate: -30.3%.
Estimated limits based on current volatility of 1.3%: low 0.02$, high 0.03$
Factors to consider:
- US accounted for 64.4% of revenue in the fiscal year ended 2022-12-31
- Current price 100.0% below estimated low
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [2.51$, 13.40$]
- 2023-12-31 to 2024-12-30 estimated range: [0.85$, 4.39$]
Financial Metrics affecting the CLVR estimates:
- Negative: Non-GAAP EPS, $ of -31.24 <= 0.10
- Negative: Operating profit margin, % of -62.10 <= 1.03
- Negative: Operating cash flow per share per price, % of -64.14 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -15.82 <= 3.85
- Negative: Industry inventory ratio change (median), % of 3.13 > 0.49
- Negative: Industry earnings per price (median), % of -20.11 <= 1.31
Short-term CLVR quotes
Long-term CLVR plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $12.12MM | $15.37MM | $17.80MM |
| Operating Expenses | $38.96MM | $54.07MM | $46.96MM |
| Operating Income | $-26.85MM | $-38.70MM | $-29.16MM |
| Non-Operating Income | $-9.83MM | $-5.98MM | $-43.30MM |
| Interest Expense | $4.46MM | $6.82MM | $2.70MM |
| R&D Expense | $1.01MM | $1.55MM | $1.72MM |
| Income(Loss) | $-36.67MM | $-44.68MM | $-72.45MM |
| Taxes | $4.74MM | $0.95MM | $-6.35MM |
| Profit(Loss) | $-41.41MM | $-45.63MM | $-66.10MM |
| Stockholders Equity | $95.25MM | $72.77MM | $40.41MM |
| Inventory | $10.19MM | $15.41MM | $8.40MM |
| Assets | $165.88MM | $116.16MM | $52.10MM |
| Operating Cash Flow | $-21.96MM | $-36.23MM | $-29.07MM |
| Capital expenditure | $3.67MM | $7.28MM | $1.31MM |
| Investing Cash Flow | $-3.67MM | $-7.28MM | $1.19MM |
| Financing Cash Flow | $91.84MM | $1.83MM | $3.29MM |
| Earnings Per Share* | $-49.93 | $-53.29 | $-51.65 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.